C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1992
10/29/1992	CA2108786A1 Compositions and methods for endothelial binding
10/29/1992	CA2108264A1 Use of mullerian inhibiting substance for treatment of certain tumors
10/28/1992	EP0511116A1 Antigens recognized by polyarthrits rheumatoid antibodies, preparation and applications
10/28/1992	EP0511011A1 Novel antibodies and methods for their use
10/28/1992	EP0510902A1 Immunoassay for detecting group B streptococcus
10/28/1992	EP0510691A1 DNA coding for human cell surface antigen
10/28/1992	EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
10/28/1992	EP0510075A1 Human receptor of tsh. sequence coding for such receptor
10/28/1992	EP0374172B1 Assay for 1,25-dihydroxy vitamin d
10/28/1992	EP0243485B1 Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin
10/28/1992	CN1065729A Monoclonal antibodies
10/27/1992	US5159066 Recombination activating gene (RAG-1)
10/27/1992	US5159064 Subjecting solution to pH of about 4 a temperature of at least 5 degrees delsius for at least 16 hours
10/27/1992	US5158893 Determining prognosis of malignat carcinoma by detecting cell specific human deratin protein marker distribution and comparing with known marker distributions
10/27/1992	US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof
10/27/1992	US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
10/27/1992	US5158769 Genetic engineering; polypeptide protective coating for vaccine
10/27/1992	CA1309340C Cationized antibodies for delivery through the blood-brain barrier
10/22/1992	DE4112743A1 Peptide(s) for hepatitis-C virus detection
10/21/1992	EP0509819A1 Monoclonal antibodies for measuring okadaic acid
10/21/1992	EP0509553A1 Anti-lymphotoxin antibody, its production and use
10/21/1992	EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin
10/21/1992	EP0509006A1 Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
10/21/1992	EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/21/1992	EP0481000A4 Receptors for fibroblast growth factors
10/21/1992	EP0190205B1 Method for determining mimotopes
10/21/1992	CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
10/20/1992	US5157140 Esters of myo-inositol phosphate
10/20/1992	US5157113 Removal of nucleic acids from monoclonal antibody preparations
10/20/1992	US5157112 Antibodies immunoreactive with the T-cell growth factor, P40
10/20/1992	US5157104 Antitumor, anticarcinogenic agents
10/20/1992	US5157020 Two covalently bonded peptides
10/20/1992	US5156977 Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use
10/20/1992	US5156965 Monoclonal antibodies
10/20/1992	US5156950 Using labeled monoclonal antibodies which recognize apoproteins
10/20/1992	US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens
10/20/1992	CA2065658A1 Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
10/20/1992	CA1309041C Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i
10/20/1992	CA1309040C Anti-melanoma antibody mg-21 for diagnosis and therapy of human tumors
10/20/1992	CA1309039C Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
10/19/1992	WO1992018540A1 Anti-human immunodeficiency virus recombinant antibodies
10/17/1992	WO1992018643A1 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
10/17/1992	CA2108565A1 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
10/16/1992	WO1992018148A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992	CA2108467A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/15/1992	WO1992017785A1 Detection of salmonella
10/15/1992	WO1992017606A1 Microassay system and neutrophil derived secretagogue
10/15/1992	WO1992017604A1 Anti-eda monoclonal antibody
10/15/1992	WO1992017603A1 Anti-eca antibodies and their applications in specific detection and possibly for the count of whole enterobacteriaceae using an immunochemical method
10/15/1992	WO1992017602A1 Parathyroid hormone receptor and dna encoding same
10/15/1992	WO1992017588A2 METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI
10/15/1992	WO1992017567A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	WO1992017506A1 MODULATION OF tPA ACTIVITY BY HEPARIN FRAGMENTS
10/15/1992	WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992	WO1992017499A1 A unique hexapeptide derived from thrombospondin and its uses
10/15/1992	WO1992017498A1 Product and method for improving keratinocyte adhesion to the dermis
10/15/1992	WO1992017497A1 Human pf4a receptors and their use
10/15/1992	WO1992017493A2 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
10/15/1992	WO1992017486A1 Totipotent hematopoietic stem cell receptors and their ligands
10/15/1992	WO1992017207A1 MONOCLONAL ANTIBODIES WHICH BIND TO SECRETED AND MEMBRANE-BOUND IgE, BUT NOT TO IgE ON BASOPHILS
10/15/1992	WO1992017206A1 Wound healing
10/15/1992	WO1992017204A1 Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria
10/15/1992	WO1992017199A1 Compositions and methods for treating small cell and nonsmall cell lung cancers
10/15/1992	WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992	WO1992017193A1 Medicament containing an agent inhibiting in vivo pathological apoptosis and applications thereof
10/15/1992	WO1992017130A1 Local immunosuppression by polymer release of defined combinations of immunosuppressants
10/15/1992	WO1992011367A3 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/15/1992	WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/15/1992	CA2407304A1 Human pf4a receptors and their use
10/15/1992	CA2116362A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	CA2103551A1 Method for production of an iga binding protein derived from group b streptococci
10/14/1992	EP0508809A1 Proteinaceous lipid-containing particles
10/14/1992	EP0508472A2 Method of producing hybridomas
10/14/1992	EP0508427A2 Method and kit for measuring anti-EBNA antibodies
10/14/1992	EP0508417A2 Monoclonal antibody, polypeptides and production thereof
10/14/1992	EP0508282A2 Anti-idiotypic monoclonal antibodies
10/14/1992	EP0508221A1 Somatostatin receptor
10/14/1992	EP0507948A1 Monoclonal antibody, hybridomas, their production and use
10/14/1992	EP0507934A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics
10/14/1992	EP0507908A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
10/14/1992	EP0507868A1 Diagnostic probe for detecting human stomach cancer
10/14/1992	EP0507867A1 Papillomavirus (hpv63) probe, particularly for the in vitro diagnosis of papillomavirus infections, possibly accompanied by genital neoplasias, and products genetically and immunologically linked to this papillomavirus
10/14/1992	EP0507852A1 Gene deleted in colorectal cancer of humans
10/14/1992	EP0507839A1 Method of separating haemopoietic progenitor cells.
10/14/1992	EP0507836A1 Novel fibronectin receptor
10/13/1992	US5155218 Dna encoding human 5-ht1d receptors
10/13/1992	US5155217 Ongogene encoding polypeptide having growth factor activity
10/13/1992	US5155213 Method for isolating IgAs in the feces
10/13/1992	US5155212 Substituted phencyclidine compound linked to polyamino acid
10/13/1992	US5155027 Culturing cells having DNA construct encoding a polypeptide having a nonimmuno- and an immunologlobulin chain which dimerize to become biologically active
10/13/1992	CA1308677C Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
10/13/1992	CA1308676C Anti-human igg (immunoglobulin g) monoclonal antibody and process for preparing the same
10/11/1992	WO1992018641A1 Interleukin-8 receptors and related molecules and methods
10/11/1992	WO1992018621A1 Proteinaceous lipid-containing particles
10/11/1992	CA2107879A1 Proteinaceous lipid-containing particles
10/11/1992	CA2107682A1 Interleukin-8 receptors and related molecules and methods
10/11/1992	CA2065690A1 Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
10/11/1992	CA2065681A1 Method of producing hybridomas
10/10/1992	CA2065602A1 Method and kit for measuring anti-ebna antibodies
10/07/1992	EP0507615A1 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)

1 ... 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 ... 1494